Bill Maughan
Stock Analyst at Clear Street
(0.55)
# 4,286
Out of 5,138 analysts
19
Total ratings
33.33%
Success rate
-23.99%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bill Maughan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLLS Cellectis | Initiates: Buy | $9 | $4.09 | +120.32% | 1 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $22 → $47 | $14.07 | +234.04% | 2 | Dec 9, 2025 | |
| ANNX Annexon | Initiates: Buy | $17 | $6.16 | +175.97% | 1 | Dec 2, 2025 | |
| KRRO Korro Bio | Initiates: Buy | $93 | $8.80 | +956.82% | 1 | Oct 31, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Buy | $100 | $44.00 | +127.27% | 1 | Sep 17, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $190 | $282.01 | -32.63% | 1 | Jul 1, 2025 | |
| CRSP CRISPR Therapeutics AG | Downgrades: Hold | $45 | $54.21 | -16.99% | 1 | Jun 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $16 → $15 | $1.96 | +665.31% | 2 | May 10, 2024 | |
| FATE Fate Therapeutics | Maintains: Buy | $11 → $9 | $1.05 | +757.14% | 1 | May 10, 2024 | |
| IMCR Immunocore Holdings | Maintains: Hold | $63 → $67 | $32.75 | +104.58% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $91 → $106 | $39.36 | +169.31% | 3 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $2.30 | +943.48% | 1 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.47 | +827.36% | 1 | Feb 21, 2024 |
Cellectis
Dec 23, 2025
Initiates: Buy
Price Target: $9
Current: $4.09
Upside: +120.32%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $22 → $47
Current: $14.07
Upside: +234.04%
Annexon
Dec 2, 2025
Initiates: Buy
Price Target: $17
Current: $6.16
Upside: +175.97%
Korro Bio
Oct 31, 2025
Initiates: Buy
Price Target: $93
Current: $8.80
Upside: +956.82%
Dianthus Therapeutics
Sep 17, 2025
Initiates: Buy
Price Target: $100
Current: $44.00
Upside: +127.27%
Krystal Biotech
Jul 1, 2025
Initiates: Buy
Price Target: $190
Current: $282.01
Upside: -32.63%
CRISPR Therapeutics AG
Jun 27, 2025
Downgrades: Hold
Price Target: $45
Current: $54.21
Upside: -16.99%
Nkarta
May 10, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $1.96
Upside: +665.31%
Fate Therapeutics
May 10, 2024
Maintains: Buy
Price Target: $11 → $9
Current: $1.05
Upside: +757.14%
Immunocore Holdings
May 9, 2024
Maintains: Hold
Price Target: $63 → $67
Current: $32.75
Upside: +104.58%
May 3, 2024
Maintains: Hold
Price Target: $91 → $106
Current: $39.36
Upside: +169.31%
Mar 15, 2024
Maintains: Buy
Price Target: $22 → $24
Current: $2.30
Upside: +943.48%
Feb 21, 2024
Reiterates: Buy
Price Target: $60
Current: $6.47
Upside: +827.36%